Current status and recent progress of second-line drugs for autoimmune hepatitis
Autoimmune hepatitis (AIH) is an immune-mediated liver parenchymal inflammation with hepatocytes as target cells. Second-line drugs can be used for patients who have suboptimal response or intolerance to the standard treatment of AIH. This article reviews the research advances in second-line drugs f...
Main Author: | |
---|---|
Format: | Article |
Language: | zho |
Published: |
Editorial Department of Journal of Clinical Hepatology
2018-05-01
|
Series: | Linchuang Gandanbing Zazhi |
Subjects: | |
Online Access: | http://www.lcgdbzz.org/qk_content.asp?id=9075 |